FORT LAUDERDALE, Fla., Oct. 27, 2017 (GLOBE NEWSWIRE) -- OmniComm Systems, Inc. (OTCQX:OMCM) announced today that Kim Rejndrup has joined the company as the senior vice president of product development. Mr. Rejndrup spent nearly 20 years at Oracle Corporation, where he was a vice president of development for many of Oracle’s clinical research applications, including systems for electronic data capture (EDC), clinical trials management, data management, medical coding and data warehousing. In his new position at OmniComm, he will be based in the company’s Fort Lauderdale headquarters, where his extensive technical and industry experience will drive OmniComm’s products to new levels of excellence and innovation.
“The company’s broad, feature-rich product line and team of very talented individuals inspired me to join OmniComm,” Mr. Rejndrup said. “I am very pleased to be a part of this elite development group, and I look forward to helping the company expand its presence in the clinical software marketplace.”
OmniComm’s management team includes industry thought leaders with decades of combined experience in the clinical software marketplace and executive experience at other leading companies that provide EDC products to the life sciences industry. For example, Keith Howells, OmniComm’s chief technology officer, has more than 25 years of experience in building and implementing clinical research applications, including five years as the head of development for Oracle’s pharmaceutical application suite and five years as the head of development for Medidata Solutions.
“I worked with Kim for many years, and I know personally that he is one of the best in the business,” Mr. Howells said. “I am absolutely delighted that he’s chosen to join us. As we prepare for a major new release of TrialMaster early next year, his talents will be invaluable in guiding both technical and functional improvements in our products.”
About OmniComm Systems, Inc.
OmniComm Systems, Inc. is a leading strategic software solutions provider to the life sciences industry. OmniComm is dedicated to helping the world’s pharmaceutical, biotechnology, contract research organizations (CROs), diagnostic and device firms, and academic medical centers maximize the value of their clinical research investments. Through the use of innovative and progressive technologies, these organizations drive efficiency in clinical development, better manage their risks, ensure regulatory compliance and manage their clinical operations performance. With an extensive global experience from more than 5,000 clinical trials, OmniComm provides comprehensive solutions for clinical research. Please visit www.omnicomm.com for more information.
OmniComm, TrialMaster, TrialOne, and Promasys are registered trademarks of OmniComm Systems, Inc. Other names may be trademarks of their respective owners.
Kuno van der Post
OmniComm Systems, Inc.
Source:OmniComm Systems Inc.